Your session is about to expire
← Back to Search
mHealth Intervention for Severe Mental Illness (tFOCUS Trial)
N/A
Waitlist Available
Led By Ethan Moitra, PhD
Research Sponsored by Butler Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 24 weeks
Awards & highlights
tFOCUS Trial Summary
This trial aims to use a mobile app to help bridge the gap between hospital and outpatient care for people with mental illness, improving continuity of care.
Who is the study for?
This trial is for adults over 18 who speak and read English, have been hospitalized or in partial hospitalization for schizophrenia-spectrum disorder or major mood disorders like bipolar disorder and depression, and plan to continue mental health treatment after discharge. It's not for those without a smartphone, unstable housing situations, or if they're being discharged to long-term restricted living.Check my eligibility
What is being tested?
The study tests the Transition-FOCUS (tFOCUS) mobile app designed to help patients with severe mental illness transition from hospital to outpatient care. The aim is to see if this mHealth intervention can make the change safer and more efficient.See study design
What are the potential side effects?
Since tFOCUS is a mobile app intervention aimed at improving continuity of care rather than a medication, it does not have traditional side effects. However, users may experience stress or anxiety related to technology use or reminders of their condition.
tFOCUS Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 24 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~24 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Brief Psychiatric Rating Scale (BPRS)
Other outcome measures
Recovery Assessment Scale (RAS)
tFOCUS Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Transition-FOCUS mHealth InterventionExperimental Treatment1 Intervention
All participants will download the tFOCUS app to their mobile phone. tFOCUS uses EMA to assess variables identified as being salient to treatment engagement and illness self-management. The application delivers algorithm-driven micro interventions to address reported problem(s). Data is transmitted to a clinician "dashboard," which can be used for remote monitoring.
Group II: Check-InActive Control1 Intervention
Control participants will receive the currently recommended best practices of post-discharge care, including follow-up appointments, instructions, referrals and a follow-up check in.
Find a Location
Who is running the clinical trial?
National Institute of Mental Health (NIMH)NIH
2,789 Previous Clinical Trials
2,690,250 Total Patients Enrolled
250 Trials studying Schizophrenia
89,278 Patients Enrolled for Schizophrenia
Brown UniversityOTHER
456 Previous Clinical Trials
558,124 Total Patients Enrolled
7 Trials studying Schizophrenia
323 Patients Enrolled for Schizophrenia
Butler HospitalLead Sponsor
129 Previous Clinical Trials
16,238 Total Patients Enrolled
2 Trials studying Schizophrenia
92 Patients Enrolled for Schizophrenia
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have been diagnosed with schizophrenia or a major mood disorder.I am 18 years old or older.I plan to continue mental health treatment after leaving the hospital.I am being discharged to a place where I will receive long-term care.I have been diagnosed with schizophrenia or a major mood disorder.I will continue mental health treatment after leaving the hospital.
Research Study Groups:
This trial has the following groups:- Group 1: Check-In
- Group 2: Transition-FOCUS mHealth Intervention
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is this experiment presently taking on new participants?
"As per the details on clinicialtrials.gov, this project is not looking for volunteers at present moment. It was first listed February 1st 2023 and most recently modified January 19th 2023; nonetheless, there are 725 other trials that require participants right now."
Answered by AI
Who else is applying?
What state do they live in?
Rhode Island
What site did they apply to?
Butler Hospital
What portion of applicants met pre-screening criteria?
Met criteria
How many prior treatments have patients received?
3+
Recent research and studies
Share this study with friends
Copy Link
Messenger